Reconstruction
In 1867, the German-born entrepreneur Henri Nestlé began selling Farine Lactée Henri Nestlé in Vevey, Switzerland. The product belonged to a new class of proprietary infant foods intended for babies who could not be breastfed. It was important, but it was not the first commercial “formula”: chemist Justus von Liebig had published and marketed his soup for infants in 1865. Nestlé’s achievement was to turn related nutritional ideas into a convenient, branded, exportable food.
Nestlé described the chief ingredients as good cow’s milk, bread or wheat flour, and sugar. In production, milk and sugar were concentrated to a paste; prepared cereal material was incorporated, and the mixture was dried and milled into a powder. Processing the cereal was meant to convert much of its starch into more soluble carbohydrates, reflecting contemporary concerns about infant digestion. Caregivers reconstituted the powder with water, reducing household preparation compared with Liebig’s multi-step recipe.
The market was shaped by grim realities. Across much of nineteenth-century Europe, roughly 15 to 25 percent of infants died before age one, with rates varying by country and community. When a mother could not nurse, families relied on wet nurses, animal milk, or cereal-and-milk paps. Urban milk could be adulterated or contaminated, while unrefrigerated mixtures and hard-to-clean bottles created severe infection risks. A shelf-stable, measured powder therefore promised consistency and portability, although it could not make unsafe water, dirty utensils, or incorrect dilution safe.
Commercial growth depended as much on distribution and authority as on recipe. Nestlé used tins, a distinctive nest trademark, printed instructions, testimonials, and direct cultivation of doctors and pharmacists. After he sold the Vevey business in 1875, its new owners employed chemists and expanded production and sales. By the late nineteenth century, Nestlé competed with condensed-milk firms and numerous proprietary infant foods across international markets. Medical opinion was never unanimous: some physicians praised the convenience, while others criticized secret or cereal-heavy compositions and preferred individualized mixtures of cow’s milk, cream, sugar, and water.
These products changed infant feeding by moving part of an intimate household and caregiving practice into factories, laboratories, pharmacies, advertising, and global trade. They could be valuable when human milk was unavailable, yet their expansion also exposed inequalities: safe preparation required money, clean water, fuel, hygienic vessels, and reliable instructions. Historical claims that a single product “solved” infant mortality are therefore promotional rather than demonstrated.
Modern infant formula descends from this industrial transformation, but not unchanged. Twentieth-century nutrition science added defined protein, fat, carbohydrate, vitamin, and mineral requirements; dairy hygiene, sterilization, packaging, and regulation improved safety. The older marketing alliance between manufacturers and medicine also generated lasting controversy, eventually contributing to the World Health Organization’s 1981 International Code of Marketing of Breast-milk Substitutes. The Vevey launch matters less as a solitary invention than as a turning point in the commercialization, standardization, and worldwide branding of infant nutrition.
Historical context
Industrialization and urban growth were changing how Europeans obtained milk and cared for infants. Railways were making relatively rapid regional food transport possible, while concentration, canning, and mechanical drying extended the life of perishable dairy products. Infant mortality remained extremely high: contemporary national rates varied, but roughly 15 to 25 percent of European infants died during their first year. Chemistry and physiology were becoming influential in medicine, encouraging attempts to measure and redesign foods. Switzerland combined a substantial dairy economy with improving transport links, helping firms in Vevey and Cham turn milk into branded products for distant markets.
Evidence
Written sources
StrongContemporary medical publications, advertisements, product instructions, business correspondence, and later archival histories directly document Nestlé’s product, its Vevey launch, and its commercial expansion.
Recipe evidence
ModeratePublished descriptions identify cow’s milk, cereal or bread material, and sugar, while company records describe concentration and drying. Exact proprietary proportions and changes between production batches are not consistently documented.
Food identification
ModerateFarine Lactée is securely identified as a commercial infant food, but calling it modern infant formula is anachronistic. Contemporary terminology more often treated it as milk flour, infant cereal, or proprietary baby food.
Dating
StrongMultiple independent and corporate historical sources place the commercial launch of Farine Lactée in Vevey in 1867. Expansion continued through the late nineteenth century, although 1900 is a period boundary rather than a discrete endpoint.
Preparation method
ModerateEvidence supports industrial concentration, cereal processing, drying, milling, packaging, and household reconstitution. Specific factory settings and household dilution practices varied and should not be reconstructed with false precision.
Geographic attribution
StrongVevey is firmly documented as the location of Henri Nestlé’s 1867 launch and early factory, although subsequent commercial expansion involved production and distribution networks far beyond Vevey.
Historical interpretation
ModerateThe connection between industrial processing, medical authority, branding, and expanded artificial feeding is well supported. Claims that the product itself substantially reduced general infant mortality are not demonstrated by controlled evidence.
Visual reconstruction
LimitedSurviving tins, labels, advertisements, factory images, and an 1897 lithograph support product and packaging imagery, but they do not directly establish typical household preparation conditions or infant outcomes.
Sources
- 1.Justus von Liebig (1865). Eine neue Suppe für Kinder. Dinglers Polytechnisches Journal, volume 176, reprinted from Annalen der Chemie und Pharmacie. dingler.bbaw.de/articles/ar176023.htmlHistorical primary source
- 2.C. P. Putnam (1876). Nestlé's Food for Babies. Boston Medical and Surgical Journal 95:551–552. doi:10.1056/NEJM187611090951903Historical primary source
- 3.Emily E. Stevens, Thelma E. Patrick, and Rita Pickler (2009). A History of Infant Feeding. The Journal of Perinatal Education 18(2):32–39. doi:10.1624/105812409X426314Scientific literature
- 4.Jacqueline H. Wolf (2020). Historical Research: The Origin of ‘Formula’: State of the Science, 1890s. Journal of Human Lactation 36(3):410–413. doi:10.1177/0890334420926950Scientific literature
- 5.Albert Pfiffner (2014). Henri Nestlé 1814–1890: From Pharmacist’s Assistant to Founder of the World’s Leading Nutrition, Health and Wellness Company. Nestlé S.A.; enhanced English edition of the 1993 German biography. www.nestle.com/asset-library/documents/about_us/Modern synthesis
- 6.Lola Wilhelm (2019). Nestlé’s Corporate Reputation and the Long History of Infant Formula. Global History of Capitalism Project, University of Oxford, Case Study 12. globalcapitalism.history.ox.ac.uk/files/case12-nModern synthesis
- 7.World Health Organization (1981). International Code of Marketing of Breast-Milk Substitutes. World Health Organization. www.who.int/publications/i/item/9241541601Historical primary source
Limitations
- moderatetitle
The 1867 Vevey event marks the launch of Nestlé’s Farine Lactée, not the beginning of commercial infant formula. Justus von Liebig published and marketed an infant-food preparation in 1865.
- moderatedescription
Farine Lactée was a milk-and-cereal proprietary infant food and was not nutritionally equivalent to modern regulated infant formula. Describing it without qualification as formula risks anachronism.
- minorcoordinates
Vevey accurately represents Nestlé’s launch and early production, but the broader expansion named in the title occurred through international manufacturing, medical, pharmacy, and distribution networks and cannot be localized solely to Vevey.
